Latest from Mayo Clinic Cancer Center

Dr. Bekaii-Saab on Immunotherapy in Colorectal Cancer

Tanios Bekaii-Saab, MD, professor of medicine, Mayo Clinic, discusses the use of immunotherapy in patients with microsatellite stable colorectal cancer.

Learning to Navigate the Neoadjuvant and Adjuvant Paradigms in Pancreatic Cancer

Tanios Bekaii-Saab, MD, discusses neoadjuvant and adjuvant strategies in treating patients with early-stage pancreatic cancer.

Dr. Hilal Discusses Rituximab Maintenance in Mantle Cell Lymphoma

Talal Hilal, MB, BCh, assistant professor of medicine, Mayo Clinic, discusses the meta-analysis of rituximab maintenance for patients with mantle cell lymphoma.

Ahn Recaps Advances and Challenges in Gastric/GEJ Cancers

Daniel Ahn, DO, discusses advances and challenges with targeted and immune-based therapies in the treatment of patients with gastric and gastroesophageal cancer.

Dr. Ramanathan Discusses the Treatment of Pancreatic Cancer

Ramesh K. Ramanathan, MD, director, Gastrointestinal Medical Oncology Program, Mayo Clinic, discusses the treatment of patients with pancreatic cancer.

Dr. Ahn on Targeted Therapies in Gastric/Gastroesophageal Cancers

Daniel H. Ahn, DO, oncologist and internist, Mayo Clinic, discusses targeted therapies in gastric/esophageal cancers.

Dr. Bekaii-Saab on the Use of Regorafenib in Patients With mCRC

Tanios Bekaii-Saab, MD, professor of medicine, Mayo Clinic, discusses the use of regorafenib (Stivarga) in patients with metastatic colorectal cancer (mCRC).

Dr. Ramanathan on Emerging Therapeutic Targets in Patients With Pancreatic Cancer

Ramesh K. Ramanathan, MD, director, Gastrointestinal Medical Oncology Program, Mayo Clinic, discusses emerging therapeutic targets in patients with pancreatic cancer.

Next Page >>

Inside Oncology

View more videos >>